The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H-pylori eradication and duodenal ulcer healing
CURRENT MEDICAL RESEARCH AND OPINION, cilt.20, sa.8, ss.1301-1307, 2004 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20 Sayı: 8
- Basım Tarihi: 2004
- Doi Numarası: 10.1185/030079904125004439
- Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1301-1307
- Kocaeli Üniversitesi Adresli: Evet
Özet
Objective: Recently, proton pump inhibitor (PPI)-based triple therapy has been recommended as a first line treatment in the eradication of Helicobacter pylori. The aim of this open, multicentre trial was to investigate the efficacy, safety, tolerability and the ulcer healing rate of a triple regimen consisting of pantoprazole(.) 40 mg, clarithromycin 500 mg and amoxicillin 1000 mg twice daily for 7 days, in the eradication of H. pylori in patients with duodenal ulcer in Turkey.